EP
LYEL icon

Essential Partners’s Lyell Immunopharma LYEL Stock Holding History

Essential Partners’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$676 Buy
+69
New +$918 ﹤0.01% 2304

Other funds holding LYEL

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners's LYEL Position: Q3 2026 in Review

Essential Partners opened a new position in Lyell Immunopharma (LYEL) in Q3 2026: 69 shares worth $676. The stake represents ﹤0.01% of the portfolio and ranks #2304 among its holdings.

5 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • Essential Partners held 69 shares of Lyell Immunopharma worth $676 as of Q3 2026.
  • Lyell Immunopharma was a new Essential Partners position in Q3 2026.
  • Lyell Immunopharma made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2304 holding.
  • 5 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.